Aptamer Group (APTA) Share Price, News & Analysis

Company Overview

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences. Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics. Through the use of its Optimer platform the Company aims to enable new opportunities, including discovery and development partnerships for improved biologic drugs, and new applications, such as novel assays and targets, to accelerate discovery and improve current standard processes. For more information, visit: https://aptamergroup.com/

Key Stats

• Today's Range: 0.37 to 0.41
• 50-Day Range: 0.33 to 0.44
• 52-Week Range: 0.20 to 1
• Volume: 24.15 million shs
• Average Volume: 14.93 million shs
• Market Capitalization: £8.15 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

APTA Stock Analysis - Frequently Asked Questions

How have APTA shares performed this year?

Aptamer Group's stock was trading at GBX 0.39 at the start of the year. Since then, APTA stock has increased by 6.5% and is now trading at GBX 0.41.
View the best growth stocks for 2025 here.

How were Aptamer Group's earnings last quarter?

Aptamer Group plc (LON:APTA) released its quarterly earnings data on Tuesday, October, 22nd. The company reported $0.71 EPS for the quarter. Aptamer Group had a negative net margin of 343.95% and a negative trailing twelve-month return on equity of 205.63%.

How do I buy shares of Aptamer Group?

Shares of APTA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

• Last Earnings: 10/22/2024
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:APTA
• CUSIP: N/A
• CIK: N/A
• Web: aptamergroup.com
• Phone: 44 1904 567 790
• Fax: N/A
• Employees: 37
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.71)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-14,165,101.63
• Net Margins: -343.95%
• Pretax Margin: N/A
• Return on Equity: -205.63%
• Return on Assets: -44.96%

Debt

• Debt-to-Equity Ratio: 92.11
• Current Ratio: 1.27
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £4.12 million
• Price / Sales: 1.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX 0.21 per share
• Price / Book: 1.92

Miscellaneous

• Outstanding Shares: 1,987,843,500
• Free Float: N/A
• Market Cap: £8.15 million
• Optionable: Not Optionable
• Beta: -0.52